The University of Toledo | Proving Resilience

Proving Resilience

Addressing the Challenges of an Enduring Pandemic Through Academic Research

From remote leadership headaches and global supply chain disruptions to COVID-19 vaccine side effects and antibody responses, UToledo tackled pandemic-related issues to give families, managers and physicians tools to improve their daily lives and work.

UToledo students sitting at an outdoor table with facemasks on

Nausea. Chills. Fatigue. Headache. Your expectations about those uncomfortable side effects from the COVID-19 vaccine are directly correlated to how you actually respond to the shot, according to research by Andrew Geers, Ph.D., professor of psychology.

Andrew Geers, Ph.D.

Individuals with higher levels of emotional intelligence did better leading remotely during the COVID-19 crisis. The leadership research by Jenell Wittmer, Ph.D., an industrial and organizational psychologist, and Margaret Hopkins, Ph.D., professor of management, showed those bosses provided strong communication, support, engagement and direction to employees.

Jenell Wittmer, Ph.D. and Margaret Hopkins, Ph.D.

Why do some immunosuppressed patients develop a robust antibody response, but others develop no response at all? Research by Stanislaw Stepkowski, Ph.D., a transplant immunologist, and Michael Rees, M.D., transplant surgeon, suggest the answer lies with the specific types of antibodies being produced after vaccination.

Michael Rees, M.D. Michael Rees, M.D.

Hypertension expert Bina Joe, Ph.D., Distinguished University Professor and chair of the Department of Physiology and Pharmacology, is using CRISPR gene-editing technology to better understand why high blood pressure is a key risk factor for serious illness with COVID-19.

Bina Joe, Ph.D. Bina Joe, Ph.D.

After the initial panic buying that cleared store shelves at the beginning of the pandemic, supply chain issues continue due to labor and materials shortages. And the disruptions will not resolve quickly, Paul Hong, Ph.D., global supply chain management expert, explains in The Hill.

Paul Hong, Ph.D.

Early in the pandemic, Muhammad Aziz, M.D., then chief internal medicine resident at UToledo, identified loss of taste as an early symptom of COVID-19 in individuals with minor illness.

Muhammad Aziz, M.D. Muhammad Aziz, M.D.

The University of Toledo Medical was one of the first hospitals in the country to participate in a national COVID-19 drug study led locally by Michael Ellis, M.D., an infectious disease specialist and chief medical officer at UTMC, to screen out ineffective experimental treatments and advance therapeutics that benefit hospitalized COVID-19 patients.

Michael Ellis, M.D.

Leveraging spatial analysis in conjunction with epidemiological data, doctoral students Kimberly Panozzo and Ishfaq Rahman created a map that forecasts COVID-19 cases to better understand how the virus spreads and improve our ability to respond.

Kim Panozzo and Ishfaq Rahman

Precise predictive models developed by doctoral students Mohammadreza Nemati and Jamal Ansary are able to forecast with 70% accuracy the recovery time of hospitalized COVID-19 patients based on their age and sex.

Mohammadreza Nemati

Research from Khalid Changal, M.D., a cardiology fellow in the UToledo College of Medicine and Life Sciences, shows how COVID-19 impacts the electrical system of the heart and causes inflammation.

Khalid Changal, M.D. Khalid Changal, M.D.

Learn More


More Features Like This:     Navigating Uncertainty     Protecting Health     Challenging Stigma    
Last Updated: 12/17/21